Fexion

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fexion

Property Description
Active ingredient Sildenafil (Sildenafil citrate)
Form Film-coated tablet (Oral administration)
Pharmacological class Phosphodiesterase type 5 inhibitor (PDE5 inhibitor)
Origin Synthetic compound

What Type of Medicine is Fexion, and What is its Composition?

Fexion is a specific, synthetic pharmaceutical formulation based on the sole active ingredient, Sildenafil, which is present as the Sildenafil citrate salt. This formulation is primarily presented as a film-coated tablet designed for oral administration, distinguishing it as a convenient, non-invasive dosage form. The medication is categorized as a single active ingredient product, meaning its effect is derived exclusively from the Sildenafil compound. Unlike combination drugs, Fexion focuses the therapeutic action entirely on the core chemical entity.


Fexion's Place in Pharmacology: The PDE5 Inhibitor Class

Fexion is chemically classified as a member of the Phosphodiesterase type 5 inhibitor (PDE5 inhibitor) class of medicines. This designation confirms the compound works by enacting the selective inhibition of phosphodiesterase type 5 (PDE5), a specific enzyme found in various vascular tissues throughout the body. By inhibiting this enzyme, Fexion is broadly categorized as a potent vasodilator agent. This class of medication specifically targets the relaxation of smooth muscle in blood vessel walls.


General Purpose: How Sildenafil Contributes to Vascular Response

The primary purpose of Fexion is to promote smooth muscle relaxation and vasodilation in targeted areas for addressing circulatory deficiencies. This is achieved by enhancing the effects of the natural nitric oxide (NO) signaling pathway. This action leads to a controlled and localized increase in blood flow, which is the fundamental mechanism utilized to address conditions related to insufficient circulation or inadequate vascular response, often seen in adult patients requiring improved peripheral blood flow. The drug acts as a physiological response amplifier, improving circulation in specific vascular beds when the appropriate natural stimulus is present.

Regulatory References

  1. National Library of Medicine
  2. EMA EPAR for Sildenafil

What side effects are possible with Fexion?

Official Classification of Possible Side Effects

The safety profile of Fexion (Sildenafil) is documented in regulatory labeling by classifying adverse reactions based on their frequency of occurrence, primarily related to the medicine's vasodilatory effects. These documented effects are grouped by the affected System-Organ Class for clarity.

The most commonly reported adverse reactions are often associated with the vascular and nervous systems. According to regulatory data, adverse reactions are officially classified as follows:

Frequency Classification Examples of Adverse Reactions (SOC)
Very Common (ge 1/10) Headache, Flushing, Pain in extremity
Common (ge 1/100 to < 1/10) Dizziness, Visual disturbances (e.g., color tinge), Nasal congestion, Dyspepsia, Back pain
Uncommon (ge 1/1,000 to < 1/100) Hypotension, Vomiting, Rash, Hypersensitivity reactions, Haematuria
Rare (ge 1/10,000 to < 1/1,000) Non-arteritic anterior ischemic optic neuropathy (NAION)

Serious Adverse Reactions and Safety Constraints

Official labeling highlights several serious adverse reactions that require attention, including the ocular event Non-arteritic anterior ischemic optic neuropathy (NAION), the reproductive system reaction Priapism (a prolonged erection that can cause permanent tissue damage), and sudden decrease or loss of hearing. Post-marketing reports also note serious cardiovascular events, such as myocardial infarction.

Fexion is officially contraindicated for use with any form of organic nitrates or guanylate cyclase (GC) stimulators due to the risk of severe, life-threatening hypotension. Population-specific safety considerations state that the medicine is contraindicated in patients with severe hepatic impairment and requires caution in patients with conditions predisposing them to Priapism or those with severe renal impairment. Regulatory documents also note that the interaction with alpha-blockers may result in symptomatic hypotension, most likely to occur within four hours of dosing.

Overdose and Emergency Response

Fexion Overdose and When to Seek Help

Overdose with Fexion (Sildenafil) is typically associated with an increased incidence of adverse reactions already observed at standard doses. Manifestations documented in regulatory labeling include Headache, Flushing, Dizziness, and Hypotension (decreased blood pressure).

Emergency Actions and Urgent Medical Attention

The regulatory profile mandates that patients seek immediate medical assistance if an erection persists for longer than 4 hours (priapism). This is considered a time-critical event which, if untreated, may result in permanent tissue damage. Additionally, patients must stop treatment and seek medical attention immediately in the event of sudden visual defect or sudden decrease or loss of hearing.

Overdose Management

Treatment for overdose is officially defined as symptomatic and supportive, as regulatory guidance confirms that no specific antidote is known for Sildenafil. Furthermore, clearance by renal dialysis is not expected to be beneficial due to the drug's high plasma protein binding. Regulatory documents also note that the effects may be increased in patients with severe hepatic impairment due to reduced clearance.

Therapeutic Uses of Fexion

What Fexion Treats: Main Uses and Benefits

The therapeutic use of Fexion is relevant across therapeutic domains where additional symptomatic support is needed. Fexion may be part of symptomatic management for conditions presenting with systemic or localized discomfort. Fexion is commonly used to help with symptoms related to physical discomfort that may appear suddenly or intensify over time, particularly symptoms related to heightened physiological activity and systemic imbalance.


Easing Symptom Fluctuation and Functional Strain

The medicine is considered relevant for managing symptom clusters that may become intense or disruptive, especially when symptoms cluster into patterns requiring supportive management. It assists with managing symptoms related to heightened physiological activity in conditions involving episodic or fluctuating manifestations.

Fexion is applied across domains where short-term symptomatic assistance is needed, helping address groups of symptoms that create noticeable functional strain and interfere with routine activities. This provides support that helps ease the overall symptom burden.


Quick Fact: Support for Episodic Discomfort Fexion is applied when symptoms become more disruptive during flare-ups and provides support that helps ease the overall symptom burden.

Eligibility and Restrictions for Use

Who Can and Cannot Use Fexion?

Eligibility for Fexion (Sildenafil) is determined strictly by official regulatory documents, defining which populations are permitted, restricted, or prohibited from use.

Contraindicated Populations (Must Not Use)

The medicine is contraindicated in patients with a few key conditions or concomitant treatments:

  • Patients using nitrates or nitric oxide donors in any form (due to risk of severe hypotension).
  • Patients using guanylate cyclase stimulators (e.g., riociguat).
  • Patients with severe hepatic impairment, a recent history of stroke or myocardial infarction, or specific hereditary degenerative retinal disorders.

Restricted or Conditional Use

Fexion is primarily indicated only for adult men (ge 18 years). Use is not indicated for the pediatric population or women.

Special consideration or use with caution is required for certain groups:

  • Severe Renal Impairment or Geriatric Patients (ge 65 years): Regulatory documents advise considering a lower starting amount.
  • Patients with conditions predisposing to priapism (e.g., sickle cell anaemia) or anatomical deformation of the penis.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fexion (Sildenafil) has formally documented interaction patterns that are classified based on the mechanism and resulting clinical restrictions defined by regulatory authorities.

Contraindicated and Restricted Combinations

Co-administration with organic nitrates (in any form) and guanylate cyclase stimulators (e.g., Riociguat) is contraindicated. This prohibition is due to a severe pharmacodynamic interaction resulting in the potentiation of hypotensive (blood pressure-lowering) effects. The regulatory profile also lists co-administration with other PDE5 inhibitors as a restriction that should be avoided.


Pharmacokinetic and Pharmacodynamic Interactions

Fexion's clearance is subject to pharmacokinetic interaction through the Cytochrome P450 (CYP) enzyme system, primarily CYP3A4. Strong inhibitors of CYP3A4 (e.g., Ritonavir, Ketoconazole) reduce Fexion's clearance, which has been officially documented to increase systemic exposure (AUC) by up to 11-fold. Co-administration with potent CYP3A4 inhibitors is formally designated as Not Recommended.

A separate pharmacodynamic interaction is documented with alpha-blockers and other antihypertensive agents, which may lead to symptomatic hypotension due to additive vasodilatory effects. The official labeling notes this hypotensive risk is most likely to occur within four hours of administration. Furthermore, patients with severe hepatic impairment exhibit a population-specific reduction in clearance, increasing systemic exposure.

Mechanism of Action

Enzyme Inhibition and cGMP Signal Amplification

Fexion's action is targeted, focused on modulating vascular tone by influencing a specific enzyme-mediated signaling pathway in the body's vascular system. The active ingredient, Sildenafil, initiates its action through the selective competitive inhibition of the enzyme Phosphodiesterase type 5 ( PDE5), which is predominantly located in vascular smooth muscle cells. This inhibition prevents the rapid hydrolysis of the chemical messenger cyclic GMP ( cGMP), thereby amplifying the cGMP-mediated relaxation signal produced by the natural Nitric Oxide ( NO) signaling pathway.

Cascade to Vascular Smooth Muscle Relaxation

The sustained, elevated level of cGMP acts as a secondary messenger that triggers a cascade of events leading to a decrease in intracellular calcium within the vessel walls. This alteration reduces the tension and causes the vascular smooth muscle to relax, a process termed vasodilation. The final physiological consequence of this mechanism is vasodilation, resulting in an increase in localized perfusion (blood flow) to the affected region.

Mechanism Dependency and Limitations

This mechanism operates as a physiological response amplifier and is fundamentally dependent on NO. Fexion does not initiate the relaxation signal itself, but rather preserves and enhances it, and therefore requires the prior release of Nitric Oxide for its action to occur.

Dosage and Administration Information

How Fexion is Used

Fexion (sildenafil) is prescribed for oral administration as a film-coated tablet, following a usage pattern that is as needed and not intended for continuous daily maintenance therapy. Administration guidelines define specific dosing rules and frequency limitations to ensure proper use.


Administration and Dosing

The standard protocol establishes a clear process for how the medication is to be taken, focusing on timing and quantity limits.

Element Instruction/Rule
Starting Dose The recommended initial dose for most adult patients is 50 mg.
Maximum Dose/Frequency The dose may be adjusted from 25 mg up to a maximum single dose of 100 mg, but must not be taken more than once per day.
Timing Relative to Activity The tablet is administered approximately one hour before activity, with a window extending from 30 minutes to 4 hours prior.
Timing Relative to Food Fexion may be taken with or without food. Taking it with a high-fat meal may lead to a delay in the onset of activity.

Population-Specific Use

Standard protocols include a reduced starting dose for certain patient populations to account for altered drug clearance:

  • A starting dose of 25 mg is advised for older adults (65 years of age and older).
  • A 25 mg starting dose is also considered for patients with severe renal impairment (creatinine clearance less than 30 mL/min) or significant hepatic impairment.

These instructions define the standardized, non-daily approach to using the medicine, focusing solely on dosage and administration conditions.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fexion

Evidence for use in Erectile Dysfunction (ED)

Research for Fexion in the context of erectile dysfunction (ED) was conducted using short-term, placebo-controlled, randomized clinical trials (RCTs). The research was applied in studies examining patient-reported experiences across a large group of adult men with varying backgrounds and causes of ED.

Studies monitored outcomes related to functional measures, particularly those assessing changes in the achievement and maintenance of an erection, using specific patient-reported measures. Findings described patterns observed in the studies where measures of function were documented to evolve differently when comparing the study drug to placebo. Research provides insight into short-term changes over periods generally lasting a few weeks to a few months.

However, the most rigorous, controlled research focused on these short-term periods. Long-term outcomes are not fully established based on double-blind RCTs, as data spanning multiple years primarily comes from open-label extension studies.


Evidence for use in Pulmonary Arterial Hypertension (PAH)

Fexion was evaluated in clinical trials for the context of Pulmonary Arterial Hypertension (PAH), a condition marked by functional limitations related to blood pressure in the lungs. These studies, including placebo-controlled RCTs, were applied in research contexts involving fluctuating or unstable symptoms of PAH.

Research examined outcomes reflecting physiological strain or stress, specifically focusing on the patient's exercise capacity, often measured by the 6-Minute Walk Distance (6MWD). Research highlights changes measured during the study period for adults, where findings indicated patterns related to the 6-Minute Walk Distance when comparing the study drug to placebo.

The certainty remains low for the pediatric population (children aged 1 to 17 years). While studies explored the use in children, regulatory reviews have noted a complexity in interpreting the long-term outcomes for this group. The follow-up durations for the controlled adult trials were limited, and information on outcomes after the initial 12 to 16 weeks is primarily derived from extended, less controlled observation periods.


Gaps in Research and Areas of Study Uncertainty

The primary limitation is that follow-up durations were limited in the most rigorous placebo-controlled trials. Long-term effects are not fully established under these controlled conditions, relying instead on observational data. Comparative evidence is lacking for certain research contexts. Additionally, subgroup findings are uncertain for many less-studied patient demographics, and research provides context but not individual predictions.

Frequently Asked Questions (FAQ)

Common questions about Fexion (FAQ)

Q: Is Fexion the same kind of drug as [Competitor Drug Name]?

Fexion belongs to the pharmacological class known as Phosphodiesterase type 5 (PDE5) inhibitors. Regulatory documents indicate that other medicines that inhibit the PDE5 enzyme are considered members of the same pharmacological class. This designation confirms they work via a similar biological pathway.

Q: Can Fexion be taken with simple painkillers like ibuprofen?

Official patient counseling generally advises individuals to inform their healthcare provider about all medicines they take, which includes over-the-counter painkillers. Since these non-prescription products are not typically subject to the same co-administration testing, co-administration should be reviewed by a healthcare provider.

Q: What happens if someone misses a dose of Fexion?

According to official product information, Fexion is prescribed for use strictly 'as needed' and is not a daily maintenance medicine. Therefore, if a dose is missed, no action is generally required, and the next dose may be taken as specified on the label prior to a future activity.

Q: What should someone expect to feel when Fexion is working?

The mechanism of Fexion involves widening blood vessels. Official safety documents list certain common effects associated with this action, such as flushing (a reddening and warming of the face and neck), dizziness, or a headache, which are associated with the drug's activity.

Q: Why is alcohol strongly discouraged while taking Fexion?

Official patient information states that consuming alcohol while using Fexion may increase the risk of certain side effects, such as dizziness or low blood pressure. Official information suggests this is due to the potential for enhanced vasodilatory (blood vessel widening) effects.

Q: How long does the effect of a Fexion dose usually last?

Pharmacokinetic data indicates that the maximum concentration of the active ingredient is reached relatively quickly. The period of measurable activity generally lasts several hours, and the terminal half-life of the active ingredient is approximately four hours.

Q: Why are children usually not eligible to use Fexion?

The use of Fexion is generally not indicated for the pediatric population. Regulatory reviews have noted complexity and uncertainty in interpreting the long-term outcomes for children, which contributes to its status as generally not indicated for this population.

Q: Can Fexion be split or crushed if someone has trouble swallowing pills?

Fexion is manufactured as a film-coated tablet for oral administration. The official instructions for use do not include information about crushing or splitting the tablets, and the medicine is supplied as a whole tablet.

Q: Does Fexion change how other prescription drugs are processed by the body?

Official drug interaction data indicates that the active ingredient in Fexion may inhibit certain enzymes, such as CYP3A4, that are involved in clearing other drugs. This process may lead to altered systemic levels of co-administered medicines.

Q: Is Fexion known to cause weight changes?

Official side effect listings indicate that potential weight changes have been reported. These include unspecified weight gain or loss, or swelling (edema) of the arms, hands, lower legs, or feet, which are described in the official safety profile.

Q: How quickly is Fexion supposed to start working?

Pharmacokinetic data shows that the active ingredient reaches its maximum concentration in the blood, on average, within 60 minutes after being taken on an empty stomach. The official label defines a usage window extending from 30 minutes to 4 hours prior to activity.

Q: Does Fexion require any special lab tests before starting it?

Routine blood work for monitoring side effects is not generally listed as required in official documents for most patients. However, a healthcare provider may suggest regular monitoring of blood pressure when the medicine is first started or the dose is changed.

Q: Can Fexion make you feel tired or drowsy during the day?

While tiredness or drowsiness are not explicitly listed among the most common adverse reactions, dizziness is a common side effect. Because of this possibility, regulatory warnings advise against driving or operating machinery until the patient is aware of how the medicine affects them.

Q: Are there any specific foods or drinks to avoid while taking Fexion?

Official patient information notes that taking Fexion with a high-fat meal may delay the time it takes for the medicine to start working. Additionally, alcohol consumption is generally discouraged due to the potential for increased side effects.

Q: Does Fexion affect birth control pills or other hormonal treatments?

Official patient information indicates that the active ingredient in Fexion is not documented to affect the mechanism or action of combined oral contraceptives or other hormonal birth control methods.

Q: Is it normal to have a slight headache when first starting Fexion?

Yes, regulatory documents list headache as a 'Very Common' side effect. This makes it one of the most frequently reported adverse reactions, particularly when a patient first begins taking the medication.

Q: Does Fexion have a risk of dependence or withdrawal?

The active ingredient in Fexion is not classified as an addictive substance by regulatory bodies. Studies and official information indicate that the medicine does not cause physical withdrawal symptoms upon discontinuation.

Q: Can Fexion be taken if I am already taking supplements?

Official patient counseling requires informing a healthcare provider of all medicines taken, including vitamins and herbal supplements. Since these products are not systematically evaluated alongside Fexion, potential compatibility concerns should be reviewed by a healthcare provider.

Q: What is Fexion used for beyond its main stated purpose?

The active ingredient in Fexion has a separate official indication under a different brand name. It acts as a vasodilator and is also approved for the treatment of Pulmonary Arterial Hypertension (PAH).

Q: Are there different forms of Fexion (e.g., tablet, liquid)?

Fexion is supplied as a film-coated tablet for oral use. However, other regulatory-approved products containing the same active ingredient are available in different forms, such as liquid or oral suspension, for the treatment of specific conditions like Pulmonary Arterial Hypertension.

Q: Does Fexion interact with common cold or flu medicines?

Fexion has known interactions with specific medicine classes, particularly those that lower blood pressure. Patients are advised to consult their healthcare provider about all over-the-counter cold and flu medicines they plan to take to check for potential interaction concerns.

Q: What should I do if I feel worse after starting Fexion?

Official patient information advises refraining from further activity and seeking immediate medical attention if certain serious symptoms occur upon initiation of activity, such as chest pain, nausea, or pain radiating to the jaw or arm.

Q: Is Fexion safe to handle, or does it require special precautions?

Official guidance requires Fexion to be stored in its original, tightly closed container to protect it from moisture. No specific handling precautions are listed, but the medicine must always be kept out of the sight and reach of children.

Q: Are there specific warnings about driving or operating machinery while on Fexion?

Official warnings advise against driving or operating machinery until the patient is aware of how the medicine affects them, due to the possibility of dizziness, visual changes, or effects on coordination and reaction time.

Q: Can people with diabetes safely take Fexion?

Clinical studies included patients diagnosed with diabetes. Diabetes itself is not listed as a contraindication, but caution is documented when the drug is used in combination with certain medicines for high blood pressure, due to the potential for additive effects.

Q: How does Fexion affect blood pressure?

As a potent vasodilator, Fexion widens blood vessels, which can lead to dose-related decreases in systemic blood pressure. Regulatory information describes this blood pressure reduction as typically being most pronounced 1 to 2 hours after a dose is taken.

Q: Do other medicines make Fexion less effective?

Regulatory documents indicate that co-administration with certain prescription drugs is known to increase the rate at which Fexion's active ingredient is cleared from the body. This increased clearance may lead to diminished activity.

Q: Is Fexion used to treat symptoms or the underlying cause of a condition?

Fexion's mechanism of action involves enhancing a natural physiological response. It acts to treat the functional limitations of a condition by promoting a specific physiological response, rather than addressing the underlying cause.

Q: Are the side effects of Fexion temporary or long-lasting?

The majority of commonly reported side effects, such as flushing and headache, are generally considered transient. They are typically associated with the medicine's peak activity period, which lasts for several hours following a dose.

Q: Can Fexion cause dizziness or lightheadedness?

Dizziness is officially listed as a 'Common' side effect in regulatory documents. Lightheadedness is a related symptom often linked to the drug's vasodilatory properties and its potential to lower blood pressure.

Q: How does Fexion affect liver function tests?

Fexion is contraindicated in patients with severe hepatic impairment (poor liver function). While routine testing is not always required, there have been rare post-marketing reports of drug-induced liver injury, suggesting a need for cautious use in patients with pre-existing liver conditions.

Q: Why might a patient need to stop Fexion treatment suddenly?

The medicine’s official warnings state that stopping use immediately and seeking urgent medical attention is required if serious adverse events occur, such as a prolonged erection (Priapism), sudden loss of vision, or sudden decrease or loss of hearing.

Q: Is Fexion available as a generic version?

The active ingredient in Fexion is Sildenafil. Official sources confirm that Sildenafil is also the non-proprietary name, or generic name, of the medicine.

How should Fexion be stored and disposed of?

How to Store and Dispose of Fexion

Official regulatory guidelines strictly define the storage and disposal of Fexion (Sildenafil) tablets to maintain product stability and ensure public safety.


Storage Requirements

Fexion must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), and must not be stored above 30 C or frozen. Keep the medicine in its original container, which must be tightly closed, to protect it from moisture. In alignment with regulatory standards, the product must be kept out of the sight and reach of children.


Disposal Instructions

Unused or expired Fexion must be disposed of in accordance with local requirements. The preferred method is to use a community drug take-back program. The tablets must not be flushed down the toilet or poured into wastewater, as the drug is not on the list of medicines recommended for disposal by flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fexion found in:

A-Z Index: